Dual bispecific protein engager–armed T cells targeting BCMA and B7-H3 overcome antigen heterogeneity in multiple myeloma

BIOMEDICINE & PHARMACOTHERAPY · Published 2026-07-24 · DOI 10.1016/j.biopha.2026.119751

Free full text

Authors (8)

Thanida Chanpong, Nunghathai Sawasdee, Kamonlapat Supimon, Thanich Sangsuwannukul, Thaweesak Chieochansin, Seiji Okada, Pa-thai Yenchitsomanus, Mutita Junking

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chanpong, T., Sawasdee, N., Supimon, K., et al. (2026). Dual bispecific protein engager–armed T cells targeting BCMA and B7-H3 overcome antigen heterogeneity in multiple myeloma. BIOMEDICINE & PHARMACOTHERAPY. https://doi.org/10.1016/j.biopha.2026.119751

Related articles

• Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers · Seminars in Hematology · 2025 · Cites or is cited by this article
• The current state and future of T-cell exhaustion research · Oxford Open Immunology · 2023 · Cites or is cited by this article
• 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal